ebomi
Colour theme
Sign in
Insider · CIK 0001347769

Column Group L P

CIK 0001347769 Name as filed on the most recent filing

Filed as Column Group L P (126)

282 transaction lines · from 126 filings · filed 2014-07-31 to 2023-11-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-08-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 646,827, acquired Open Form 4 filing 0001209191-20-048800
2020-08-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 646,827, acquired Open Form 4 filing 0001209191-20-048798
2020-08-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,800, acquired Open Form 4 filing 0001209191-20-048294
2020-08-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,800, acquired Open Form 4 filing 0001209191-20-048295
2020-08-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 197,991, acquired Open Form 4 filing 0001209191-20-048294
2020-08-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 197,991, acquired Open Form 4 filing 0001209191-20-048295
2020-08-21 P, Open-market purchase NGM Biopharmaceuticals IncNGM 131,558, acquired Open Form 4 filing 0001209191-20-048294
2020-08-21 P, Open-market purchase NGM Biopharmaceuticals IncNGM 131,558, acquired Open Form 4 filing 0001209191-20-048295
2020-08-17 P, Open-market purchase NGM Biopharmaceuticals IncNGM 114,943, acquired Open Form 4 filing 0001209191-20-046992
2020-08-17 P, Open-market purchase NGM Biopharmaceuticals IncNGM 114,943, acquired Open Form 4 filing 0001209191-20-046994
2020-08-14 P, Open-market purchase NGM Biopharmaceuticals IncNGM 664,498, acquired Open Form 4 filing 0001209191-20-046992
2020-08-14 P, Open-market purchase NGM Biopharmaceuticals IncNGM 664,498, acquired Open Form 4 filing 0001209191-20-046994
2020-08-13 P, Open-market purchase NGM Biopharmaceuticals IncNGM 355,922, acquired Open Form 4 filing 0001209191-20-046992
2020-08-13 P, Open-market purchase NGM Biopharmaceuticals IncNGM 355,922, acquired Open Form 4 filing 0001209191-20-046994
2020-07-30 P, Open-market purchase NGM Biopharmaceuticals IncNGM 13,169, acquired Open Form 4 filing 0001209191-20-044543
2020-07-30 P, Open-market purchase NGM Biopharmaceuticals IncNGM 13,169, acquired Open Form 4 filing 0001209191-20-044544
2020-07-28 P, Open-market purchase NGM Biopharmaceuticals IncNGM 73,849, acquired Open Form 4 filing 0001209191-20-044067
2020-07-28 P, Open-market purchase NGM Biopharmaceuticals IncNGM 73,849, acquired Open Form 4 filing 0001209191-20-044108
2020-07-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 68,974, acquired Open Form 4 filing 0001209191-20-043876
2020-07-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 68,974, acquired Open Form 4 filing 0001209191-20-043875
2020-07-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,232,670, acquired Open Form 4 filing 0001209191-20-043876
2020-07-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,232,670, acquired Open Form 4 filing 0001209191-20-043875
2020-07-22 P, Open-market purchase NGM Biopharmaceuticals IncNGM 3,474, acquired Open Form 4 filing 0001209191-20-043532
2020-07-22 P, Open-market purchase NGM Biopharmaceuticals IncNGM 3,474, acquired Open Form 4 filing 0001209191-20-043529
2020-04-08 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,683,400, acquired Open Form 4 filing 0001209191-20-024072
2020-04-08 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,683,400, acquired Open Form 4 filing 0001209191-20-024074
2020-04-07 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,779,209, acquired Open Form 4 filing 0001209191-20-023862
2020-04-07 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,779,209, acquired Open Form 4 filing 0001209191-20-023864
2020-04-03 P, Open-market purchase NGM Biopharmaceuticals IncNGM 181,025, acquired Open Form 4 filing 0001209191-20-023862
2020-04-03 P, Open-market purchase NGM Biopharmaceuticals IncNGM 181,025, acquired Open Form 4 filing 0001209191-20-023864
2020-04-02 P, Open-market purchase NGM Biopharmaceuticals IncNGM 184,140, acquired Open Form 4 filing 0001209191-20-022770
2020-04-02 P, Open-market purchase NGM Biopharmaceuticals IncNGM 184,140, acquired Open Form 4 filing 0001209191-20-022767
2020-04-01 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,447,501, acquired Open Form 4 filing 0001209191-20-022770
2020-04-01 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,447,501, acquired Open Form 4 filing 0001209191-20-022767
2020-03-31 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,479,380, acquired Open Form 4 filing 0001209191-20-022770
2020-03-31 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,479,380, acquired Open Form 4 filing 0001209191-20-022767
2020-03-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 30,176, acquired Open Form 4 filing 0001209191-20-021181
2020-03-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 30,176, acquired Open Form 4 filing 0001209191-20-021183
2020-03-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,568,767, acquired Open Form 4 filing 0001209191-20-021181
2020-03-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,568,767, acquired Open Form 4 filing 0001209191-20-021183
2020-03-23 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,981,601, acquired Open Form 4 filing 0001209191-20-021181
2020-03-23 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,981,601, acquired Open Form 4 filing 0001209191-20-021183
2020-03-20 P, Open-market purchase Constellation Pharmaceuticals IncCNST 128,228, acquired Open Form 4 filing 0001209191-20-020732
2020-03-20 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,684,075, acquired Open Form 4 filing 0001209191-20-020687
2020-03-20 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,684,075, acquired Open Form 4 filing 0001209191-20-020683
2020-03-20 P, Open-market purchase Constellation Pharmaceuticals IncCNST 128,228, acquired Open Form 4 filing 0001209191-20-020728
2020-03-19 P, Open-market purchase Constellation Pharmaceuticals IncCNST 808,701, acquired Open Form 4 filing 0001209191-20-020732
2020-03-19 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,720,698, acquired Open Form 4 filing 0001209191-20-020687
2020-03-19 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,720,698, acquired Open Form 4 filing 0001209191-20-020683
2020-03-19 P, Open-market purchase Constellation Pharmaceuticals IncCNST 808,701, acquired Open Form 4 filing 0001209191-20-020728

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. COLUMN GROUP L P, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001347769

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.